Study of NPF-08 in Patients Who Receive Colonoscopy
NCT03794310
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
632
Enrollment
INDUSTRY
Sponsor class
Conditions
Patients Who Receive Colonoscopy
Interventions
DRUG:
NPF-08 （1-day treatment）
DRUG:
NPF-08 （2-day split dose）
DRUG:
Moviprep（1-day treatment）
Sponsor
Nihon Pharmaceutical Co., Ltd